EcoDrugPlus

Kinesin Family Member 11

Ensembl ID : ENSPPRG00000014048
Gene Symbol: KIF11
4 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPPRG00000024618
Gene Symbol: KIF5B
4 Cross references
281 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSPPRG00000001567
Gene Symbol: LTA4H
4 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSPPRG00000016460
Gene Symbol: LTB4R
1 Cross references
140 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSPPRG00000020983
Gene Symbol: LTB4R2
3 Cross references
236 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSPPRG00000012548
Gene Symbol: KDM1A
4 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSPPRG00000003080
Gene Symbol: LOXL2
4 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSPPRG00000004809
Gene Symbol: MIF
4 Cross references
218 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSPPRG00000008281
Gene Symbol: MST1R
3 Cross references
266 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSPPRG00000024877
Gene Symbol: MGAM
3 Cross references
312 Possible Orthologues:

Maltase-Glucoamylase 2 (Putative)

Ensembl ID : ENSPPRG00000024888
Gene Symbol: MGAM2
3 Cross references
390 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSPPRG00000012447
Gene Symbol: MMP1
4 Cross references
352 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).